On Motion to Suspend the Rules and Pass: HR 1629
Fairness in Orphan Drug Exclusivity Act
House Roll Call #134 • 117th Congress
Failed
Roll Call #134
What This Vote Means
The House REJECTED this procedural motion.
About 1629
Fairness in Orphan Drug Exclusivity Act
See sponsors, cosponsors, summary, and legislative timeline
May 11, 2021
117th Congress, Session 1
1629 - HR
250
Yea
58.1%
168
Nay
39.1%
0
Present
0.0%
12
Not Voting
2.8%
Vote by Party
Democrats (0)
Yea: 0
Nay: 0
Republicans (0)
Yea: 0
Nay: 0
Independents (0)
Yea: 0
Nay: 0
Individual Member Votes Loading
House Roll Call: Individual member positions are being processed from official XML data.
The vote totals shown above reflect the final counts. Individual representative positions will be displayed once the XML parsing is complete. This process may take a few moments for House votes with 435 members.
Data source: congress-api•Processed: 10/3/2026•Confidence: high